SR

Sarang Ramrao Suryawanshi

Active Director Director DIN 09306735
DIN 09306735 First appointment Sep 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Sarang Ramrao Suryawanshi

Data last updated:

Sarang Ramrao Suryawanshi is a Director at Mediart Pharmaceuticals Private Limited (since 2021). The company operates in Chemicals.

DIN 09306735
Primary Designation Director
Industry Chemicals
First Appointment 04 Sep 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 Sep 20212021Active

Board colleagues of Sarang Ramrao Suryawanshi

Directorship timeline

Open interactive timeline →
Mediart Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sarang Ramrao Suryawanshi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sarang Ramrao Suryawanshi

Sarang Ramrao Suryawanshi currently holds 1 directorship: Mediart Pharmaceuticals Private Limited (Director, since 04 Sep 2021).

Sarang Ramrao Suryawanshi was first appointed on 04 Sep 2021 as Director at Mediart Pharmaceuticals Private Limited.

The current boards of Sarang Ramrao Suryawanshi's companies include Ashmeet Singh Narender Singh Arora (Mediart Pharmaceuticals Private Limited), Saurabh Thakurdas Malani (Mediart Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available